Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 110 clinical trials
featured
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

  • 102 views
  • 08 Nov, 2020
  • 1 location
featured
NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension

NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension

  • 552 views
  • 25 Mar, 2021
  • 1 location
Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)

the cardiac myocardium. Beta-blockers can antagonize the effects of catecholamine. In patients with VA-ECMO, the protective effect of beta-blocker may improve the patients' outcome. This hypothesis

  • 0 views
  • 23 Jan, 2021
  • 1 location
Pragmatic Trial of Messaging to Providers About Treatment of Heart Failure

A randomized controlled trial to compare the efficacy of an electronic health record-based alert informing providers about evidence-based medications for HFrEF versus usual care (no alert) in outpatient clinics across a single health system.

  • 0 views
  • 22 Mar, 2021
  • 1 location
Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

Clinical study evaluating selective or nonselective beta blockers use and fracture risk in patients with primary osteoporosis

  • 1 views
  • 30 Jan, 2021
  • 1 location
Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients

The major clinical problems in patients with Marfan Syndrome (MFS) are aortic root dilation (ARD), dissection and rupture. Although the available treatments (beta-blockers, BBs) improve

  • 160 views
  • 07 Nov, 2020
  • 1 location
Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by Ivabradine

), with an elevated heart rate (sinus rhythm with HR ≥ 90 bpm) and contraindications to beta-blockers (BBs). Treatment period will last 4 days. All patients will be followed for up to six months.

organ dysfunction syndrome
beta-blockers
  • 2 views
  • 08 Nov, 2020
  • 1 location
Descriptive Study of Drug Compliance in Uncontrolled Hypertensive Patients

months using an electronic pill. The antihypertensive treatments considered for the study belong to the following classes: diuretics, beta-blockers, calcium-blockers, ACE (angiotensin-converting enzyme

  • 0 views
  • 23 Jan, 2021
  • 2 locations
Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging

The proposed clinical trial is relevant to public health because it is expected to expand the differential diagnosis and provide an evidence--based therapy for the large population of patients with angina in the absence of obstructive CAD who currently remain undiagnosed and untreated. It, therefore, upholds an important part of …

  • 0 views
  • 26 Jan, 2021
  • 1 location
Autonomic Determinants of POTS - Pilot1

Postural tachycardia syndrome (POTS) is a relatively common condition affecting mostly otherwise healthy young women. It is the cause of significant disability and an impairment in quality of life. These patients have high heart rate and symptoms during standing. Many of these patients are disabled and have a poor quality …

orthostatic hypotension
moxonidine
  • 11 views
  • 31 Jan, 2021
  • 1 location